Jiahuai Tan

826 total citations
16 papers, 687 citations indexed

About

Jiahuai Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jiahuai Tan has authored 16 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jiahuai Tan's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Jiahuai Tan is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Jiahuai Tan collaborates with scholars based in United States, United Kingdom and Netherlands. Jiahuai Tan's co-authors include Shundong Cang, Delong Liu, Richard Petrillo, Yuehua Ma, Dennis E. Hallahan, Ling Geng, E. Edwards, Edwin F. Donnelly, Halina Onishko and Eric T. Shinohara and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jiahuai Tan

15 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiahuai Tan United States 8 548 165 95 67 52 16 687
Takuma Shikata Japan 8 457 0.8× 154 0.9× 85 0.9× 52 0.8× 66 1.3× 10 620
Kristina West United States 9 646 1.2× 187 1.1× 68 0.7× 87 1.3× 80 1.5× 12 819
Marica Gemei Italy 17 371 0.7× 248 1.5× 199 2.1× 59 0.9× 37 0.7× 30 666
Christopher Ware United States 10 380 0.7× 192 1.2× 73 0.8× 46 0.7× 71 1.4× 11 715
Ignazia Tusa Italy 14 336 0.6× 117 0.7× 114 1.2× 53 0.8× 39 0.8× 30 597
Scott Ackler United States 8 472 0.9× 233 1.4× 38 0.4× 76 1.1× 94 1.8× 10 625
Marsha Crochiere United States 12 471 0.9× 176 1.1× 59 0.6× 30 0.4× 36 0.7× 35 618
Andrew Capen United States 9 511 0.9× 212 1.3× 89 0.9× 121 1.8× 103 2.0× 19 724
Shengyan Xiang United States 16 765 1.4× 273 1.7× 109 1.1× 48 0.7× 61 1.2× 25 919
Grace R. Anderson United States 11 573 1.0× 190 1.2× 210 2.2× 50 0.7× 47 0.9× 13 763

Countries citing papers authored by Jiahuai Tan

Since Specialization
Citations

This map shows the geographic impact of Jiahuai Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiahuai Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiahuai Tan more than expected).

Fields of papers citing papers by Jiahuai Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiahuai Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiahuai Tan. The network helps show where Jiahuai Tan may publish in the future.

Co-authorship network of co-authors of Jiahuai Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiahuai Tan. A scholar is included among the top collaborators of Jiahuai Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiahuai Tan. Jiahuai Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lim, Sun Min, Jianjun Zhang, Nir Peled, et al.. (2025). 58P: Subcutaneous (SC) after intravenous (IV) amivantamab in advanced NSCLC: Initial results from PALOMA-2. Journal of Thoracic Oncology. 20(3). S46–S47.
2.
Tan, Jiahuai, Nilanjan Chaudhuri, Crispin T. Hiley, et al.. (2025). Delphi Consensus on Managing Non-Small Cell Lung Cancer (NSCLC) in Patients with Coexisting Interstitial Lung Disease. International Journal of Radiation Oncology*Biology*Physics. 123(1). e208–e208. 1 indexed citations
4.
5.
Mitchell, R. Brian, Patricia Rich, Paul R. Walker, et al.. (2020). Real-world performance of blood-based host immune profiling in first-line immunotherapy treatment in advanced-stage non-small cell lung cancer.. Journal of Clinical Oncology. 38(15_suppl). 9545–9545. 1 indexed citations
6.
Tan, Jiahuai, Lance K. Heilbrun, Joseph A. Fontana, et al.. (2012). Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 30(5_suppl). 415–415. 1 indexed citations
7.
Tan, Jiahuai, Naven Chetty, Srinivas Kondalsamy‐Chennakesavan, et al.. (2010). Applying the FIGO 2009 staging system for carcinoma of the vulva to patients previously staged with the FIGO 1988 staging system. Gynecologic Oncology. 116(3). 1 indexed citations
8.
Tan, Jiahuai, Shundong Cang, Yuehua Ma, Richard Petrillo, & Delong Liu. (2010). Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Journal of Hematology & Oncology. 3(1). 5–5. 355 indexed citations
9.
Tan, Jiahuai, et al.. (2009). t(3;9;22) 3-Way Chromosome Translocation in Chronic Myeloid Leukemia is Associated with Poor Prognosis. Cancer Investigation. 27(7). 718–722. 5 indexed citations
10.
Cuneo, Kyle C., Ling Geng, Jiahuai Tan, et al.. (2006). SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1197–1203. 23 indexed citations
11.
Geng, Ling, Eric T. Shinohara, Dong Kim, et al.. (2005). STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 64(1). 263–271. 44 indexed citations
12.
Lü, Bo, Eric T. Shinohara, E. Edwards, et al.. (2005). The Use of Tyrosine Kinase Inhibitors in Modifying the Response of Tumor Microvasculature to Radiotherapy. Technology in Cancer Research & Treatment. 4(6). 691–698. 10 indexed citations
13.
Geng, Ling, Jiahuai Tan, Eric Himmelfarb, et al.. (2004). A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction. Cancer Research. 64(14). 4893–4899. 40 indexed citations
14.
Tan, Jiahuai & Dennis E. Hallahan. (2003). Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.. PubMed. 63(22). 7663–7. 42 indexed citations
15.
Edwards, E., Ling Geng, Jiahuai Tan, et al.. (2002). Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation.. PubMed. 62(16). 4671–7. 132 indexed citations
16.
Tan, Jiahuai, John Wooley, & Wallace M. LeStourgeon. (2000). Nuclear Matrix-like Filaments and Fibrogranular Complexes Form through the Rearrangement of Specific Nuclear Ribonucleoproteins. Molecular Biology of the Cell. 11(5). 1547–1554. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026